Sydney, Dec 8, 2014 - (ABN Newswire) - Melbourne bio-technology firm, Rhinomed (ASX:RNO) is pleased to announce the release of its newest device from its nasal respiratory technology stable of products, Mute(TM), a nasal breathing aid to alleviate snoring and improve sleep quality.
Mute(TM) was successfully registered last week with the US FDA, Australian TGA and given permission to use the CE Mark from the European authority. As a result Rhinomed has fast tracked the online release of the technology, which can now be purchased directly from the company at www.mutesnoring.com.
In a recent independently conducted trial (results previously announced December 2, 2014), Mute(TM) achieved the primary endpoints - significant reduction in snoring severity, volume, frequency and duration. The trial (n=236) results excee ded in pre-specified criteria showing clear improvement in reported sleep quality for both the snorer and partner.
Given the prevalence of snoring in Australia and around the world, Rhinomed has commenced dialogue with pharmacy and specialty grocery groups to stock Mute in 2015, ensuring this break-through product will be readily available to anyone who needs to breathe more and snore less.
Rhinomed CEO Michael Johnson commented, “We will commence the test marketing of Mute(TM) in Australia now by rolling out our online program before extending into the pharmacy retail sector.
Our trial results clearly show Mute(TM) has a clear benefit for those who snore or suffer from night-time nasal congestion.
Mute(TM) can clearly improve the sleep quality of both the snorer and their partner and with Christmas fast approaching, Mute(TM) can give Australian couples the silent night they crave.
We are thrilled to be able to start shipping Mute(TM) from today.”
The company’s promotion campaign will commence with radio advertising in Melbourne before Christmas and will be followed by a PR, social media and targeted sampling campaign which will include a presence in the January edition of Women’s Weekly.
Mute(TM) can be ordered online at:
http://www.mutesnoring.com
WEB: Mute on sale at www.mutesnoring.com
About: Rhinomed Limited
Rhinomed Limited is a medical technology firm that focuses on nasal, respiratory and breathing management technologies. The company is monetising its technology portfolio in the Sport and recreation market, Sleep, Wellbeing and Drug delivery markets.
Rhinomed’s technology is designed to radically improve the way you breathe sleep, maintain your health and take medication.
The first product brought to market is the Turbine(TM). A radical nasal technology that improves airflow by an average of 38%, the Turbine(TM) is an internal nasal dilator that has since it’s launch in January 2014 in Australia, grown to be widely adopted by leading cyclists and triathletes globally.
Now shipped to over 36 countries and with a growing global distribution base, the Turbine(TM) is providing all those undertaking aerobic activities with an opportunity to breathe better, perform better and get more enjoyment from their sport and exercise.
Help employers find you! Check out all the jobs and post your resume.
